Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pacira BioSciences, Inc. - Common Stock
(NQ:
PCRX
)
24.19
+0.12 (+0.50%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pacira BioSciences, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
4 Analysts Have This to Say About Pacira BioSciences
↗
August 03, 2023
Via
Benzinga
Pacira BioSciences Reports Second Quarter 2023 Financial Results
August 02, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023
July 26, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Analyst Ratings for Pacira BioSciences
↗
July 13, 2023
Via
Benzinga
Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference
May 31, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Looking Into Pacira BioSciences's Return On Capital Employed
↗
May 09, 2023
Via
Benzinga
Recap: Pacira BioSciences Q1 Earnings
↗
May 03, 2023
Via
Benzinga
Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference
May 09, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Why Pacira BioSciences Shares Are Trading Lower Today
↗
May 03, 2023
Pacira BioSciences Inc (NASDAQ: PCRX) reported Q1 sales of $160.3 million compared to $158.0 million a year ago and the
Via
Benzinga
Pacira BioSciences Reports First Quarter 2023 Financial Results
May 03, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
April 26, 2023
From
Pacira BioSciences
Via
GlobeNewswire
What 6 Analyst Ratings Have To Say About Pacira BioSciences
↗
April 20, 2023
Via
Benzinga
Analyst Expectations for Pacira BioSciences's Future
↗
February 28, 2023
Via
Benzinga
Earnings Preview For Pacira BioSciences
↗
February 27, 2023
Via
Benzinga
Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
April 20, 2023
PGA TOUR Champions Golfer, Paul Goydos, Promotes Further Awareness of Non-Opioids with 2023 Partnership
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer
April 19, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
April 12, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Where Pacira BioSciences Stands With Analysts
↗
January 31, 2023
Via
Benzinga
Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources
April 03, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures
March 29, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit
March 27, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors
March 22, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference
March 08, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results
February 28, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Earnings Scheduled For February 28, 2023
↗
February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.
Via
Benzinga
LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions
February 23, 2023
Multi-year agreement will make Pacira’s medical device ioveraº the Official Non-Opioid Pain Management Partner of the LPGA
From
Pacira BioSciences
Via
GlobeNewswire
Pacira to Report 2022 Financial Results on Tuesday February 28, 2023
February 21, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
↗
January 23, 2023
On Monday, 12 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
January 10, 2023
Tuesday's session saw 16 companies set new 52-week lows.
Via
Benzinga
Pacira BioSciences Reports Preliminary Unaudited Total Revenue for 2022 of $666.8 Million
January 05, 2023
EXPAREL average daily sales 104% of the prior year for the fourth quarter and 107% of the prior year for the month of December
From
Pacira BioSciences
Via
GlobeNewswire
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today